C927-0353 Screening compound: N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]methyl}-2,3-dihydro-1,4-benzodioxine-6-sulfonamide

C927-0353 Screening compound: N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]methyl}-2,3-dihydro-1,4-benzodioxine-6-sulfonamide
C927-0353 Screening compound: N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]methyl}-2,3-dihydro-1,4-benzodioxine-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C927-0353
N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]methyl}-2,3-dihydro-1,4-benzodioxine-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C927-0353

Molecular Formula

C19H18N2O5S2 (C19 H18 N2 O5 S2)

Compound Name

N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]methyl}-2,3-dihydro-1,4-benzodioxine-6-sulfonamide

IUPAC name

N-{[2-(4-methoxyphenyl)-13-thiazol-4-yl]methyl}-23-dihydro-14-benzodioxine-6-sulfonamide

SMILES

COc(cc1)ccc1-c1nc(CNS(c(cc2)cc3c2OCCO3)(=O)=O)cs1

InChI

InChI=1S/C19H18N2O5S2/c1-24-15-4-2-13(3-5-15)19-21-14(12-27-19)11-20-28(22,23)16-6-7-17-18(10-16)26-9-8-25-17/h2-7,10,12,20H,8-9,11H2,1H3

InChI Key

LNRMZYIMYIPODR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05906173

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.035

Distribution Coefficient, logD

3.034

Water Solubility, LogSw

-3.53

Polar Surface Area

75.593

Acid Dissociation Constant (pKa)

9.92

Base Dissociation Constant (pKb)

1.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

C927-0353 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Anti-Aging Library (44940 compounds)

Antiviral Library (67538 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C927-0353 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C927-0353?
Check Price and Availability of C927-0353, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C927-0353 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C927-0353
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C927-0353
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C927-0353 available by request